- Home
- CTMX vs SFWL Comparison
CTMX vs SFWL Comparison
Compare CTMX & SFWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- SFWL
- Stock Information
- Founded
- CTMX 2008
- SFWL 2001
- Country
- CTMX United States
- SFWL China
- Employees
- CTMX N/A
- SFWL N/A
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- SFWL Trucking Freight/Courier Services
- Sector
- CTMX Health Care
- SFWL Industrials
- Exchange
- CTMX Nasdaq
- SFWL Nasdaq
- Market Cap
- CTMX 349.6M
- SFWL 82.3M
- IPO Year
- CTMX 2015
- SFWL 2023
- Fundamental
- Price
- CTMX $2.04
- SFWL $1.17
- Analyst Decision
- CTMX Strong Buy
- SFWL
- Analyst Count
- CTMX 4
- SFWL 0
- Target Price
- CTMX $5.13
- SFWL N/A
- AVG Volume (30 Days)
- CTMX 2.4M
- SFWL 25.0K
- Earning Date
- CTMX 11-06-2025
- SFWL 08-27-2025
- Dividend Yield
- CTMX N/A
- SFWL N/A
- EPS Growth
- CTMX 263.20
- SFWL 31.68
- EPS
- CTMX 0.49
- SFWL 0.14
- Revenue
- CTMX $141,100,000.00
- SFWL $540,461,000.00
- Revenue This Year
- CTMX N/A
- SFWL N/A
- Revenue Next Year
- CTMX N/A
- SFWL N/A
- P/E Ratio
- CTMX $4.06
- SFWL $8.18
- Revenue Growth
- CTMX 18.01
- SFWL 21.10
- 52 Week Low
- CTMX $0.40
- SFWL $0.86
- 52 Week High
- CTMX $3.10
- SFWL $1.60
- Technical
- Relative Strength Index (RSI)
- CTMX 47.89
- SFWL 57.95
- Support Level
- CTMX $1.90
- SFWL $1.10
- Resistance Level
- CTMX $2.16
- SFWL $1.28
- Average True Range (ATR)
- CTMX 0.13
- SFWL 0.09
- MACD
- CTMX -0.01
- SFWL 0.01
- Stochastic Oscillator
- CTMX 35.00
- SFWL 58.63
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About SFWL Shengfeng Development Limited
Shengfeng Development Ltd is a holding company. Through its subsidiaries, it offers contract logistics services in China. The contract logistics services offered by the company include planning and designing supply chains, designing facilities, processing orders, collecting payments, managing inventories, and providing client services.